Form D · Venture Capital Fund

venBio Global Strategic Fund II L.P.

San Francisco, CA · CIK 0001634632

Offering snapshot reported Mar 2, 2017 · SEC filing

Reported sold: $337M
Investors reported: 31
Minimum accepted: $0
First sale: Mar 25, 2015

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$288,000,000 → $337,000,000
Reported investors22 → 31

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 2, 2017	Amendment	$337,000,000	$49,000,000vs Mar 18, 2016	31	SEC filing
Mar 18, 2016	Amendment	$288,000,000	No comparison	22	SEC filing
Mar 19, 2015	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-236281

Source: Form D, filed Mar 2, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

VENBIO GLOBAL STRATEGIC FUND II, L.P.

Investment adviser: VENBIO PARTNERS LLC

Gross asset value: $340M
Beneficial owners: 29
ADV minimum commitment: $0

Reported in Form ADV on Mar 12, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG, LLP SAN FRANCISCO, California, United States

Custodian MORGAN STANLEY & CO. LLC SAN FRANCISCO, California, United States Related to adviser: No

Custodian SILICON VALLEY BANK SAN FRANCISCO, California, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

KPMG, LLP
PCAOB 185

MORGAN STANLEY & CO. LLC
SEC 8-15869

SILICON VALLEY BANK
LEI 0K2D5AK28E3O5CC06E35

Filing source

Form ADV 2064569 · Mar 12, 2026 · Schedule D 7.B.(1), fund 805-4937752151

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
venBio Global Strategic Fund, L.P.	Oct 29, 2013	$177,000,000	4
venBio Global Strategic Fund II L.P. (this fund)	Mar 2, 2017	$337,000,000	31
venBio Global Strategic Fund III, L.P.	Mar 26, 2020	$386,055,000	100
venBio Global Strategic Fund IV, L.P.	May 14, 2021	$549,936,000	147
venBio Global Strategic Fund V, L.P.	Jul 12, 2024	$504,700,000	162

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Robert Adelman	Director
Paul Brooke	Director
Corey Goodman	Director
N/A Ven Bio Global Strategic Gp Ii, L.P.	Director
N/A Ven Bio Global Strategic Gp Ii, Ltd.	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

1700 Owens Street Suite 595
San Francisco, CA, 94158